AROMICS is centred on the development of innovative products, services and science. Our strategy is focused on identifying, selecting and validating novel molecular biomarkers and applying them to: * Develop novel therapies against identified therapeutic targets. * Develop diagnostic tools to predict and monitor drug response. * Predict efficacy, toxicity and safety profiles of novel and existing drugs with greater accuracy. AROMICS offers pharmaceutical and biotech companies partnerships for discovering, validating and developing biomarkers in the context of drug development and diagnosis. From early research to later-stage drug development processes, AROMICS addresses novel ways of reducing drug development costs and greatly accelerating the R&D process by means of the integration of OMIC sciences in pharmaceutical development.